Anna Ehinger
21 – 30 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Molecular analyses of triple-negative breast cancer in the young and elderly
(
- Contribution to journal › Article
-
Mark
Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions
(
- Contribution to journal › Article
-
Mark
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Sex differences in oncogenic mutational processes
(
- Contribution to journal › Article
-
Mark
Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival
(
- Contribution to journal › Published meeting abstract
-
Mark
Kvalitetsbilaga för bröstpatologi (KVAST-bilaga) : Tillhörande Nationellt vårdprogram för bröstcancer
2020)(
- Other contribution › Miscellaneous
-
Mark
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice
(
- Contribution to journal › Scientific review
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532(
- Contribution to journal › Published meeting abstract
-
Mark
Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).
(
- Contribution to journal › Published meeting abstract
-
Mark
Spatial Deconvolution of HER2-positive Breast Tumors Reveals Novel Intercellular Relationships
2020)(
- Other contribution › Miscellaneous